Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-02-14 | C4 Therapeutics, Inc. | Mossler Mark
(Chief Accounting Officer) |
A | Common Stock | A | 18290 | $0.00 - $0.00 | $0 |
2024-02-15 | C4 Therapeutics, Inc. | Hirsch Andrew
(President & CEO) |
F | Common Stock | D | 6560 | $7.90 - $7.90 | $51,824 |
2024-02-14 | C4 Therapeutics, Inc. | Hirsch Andrew
(President & CEO) |
A | Common Stock | A | 103400 | $0.00 - $0.00 | $0 |
2024-02-14 | C4 Therapeutics, Inc. | REYNO LEONARD
(Chief Medical Officer) |
A | Common Stock | A | 36700 | $0.00 - $0.00 | $0 |
2024-02-13 | C4 Therapeutics, Inc. | Siegel Jolie
(Chief Legal Officer) |
F | Common Stock | D | 1735 | $6.53 - $6.53 | $11,329 |
2024-02-14 | C4 Therapeutics, Inc. | Siegel Jolie
(Chief Legal Officer) |
A | Common Stock | A | 27300 | $0.00 - $0.00 | $0 |
2024-02-13 | C4 Therapeutics, Inc. | Schick Kelly
(Chief People Officer) |
F | Common Stock | D | 1735 | $6.53 - $6.53 | $11,329 |
2024-02-14 | C4 Therapeutics, Inc. | Schick Kelly
(Chief People Officer) |
A | Common Stock | A | 27300 | $0.00 - $0.00 | $0 |
2024-02-13 | C4 Therapeutics, Inc. | Fisher Stewart
(Chief Scientific Officer) |
F | Common Stock | D | 2255 | $6.53 - $6.53 | $14,725 |
2024-02-14 | C4 Therapeutics, Inc. | Fisher Stewart
(Chief Scientific Officer) |
A | Common Stock | A | 27300 | $0.00 - $0.00 | $0 |
2024-01-02 | C4 Therapeutics, Inc. | GROGAN DONNA ROY
(Director) |
A | Common Stock | A | 2108 | $6.52 - $6.52 | $13,744 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |